Doing Human Subjects Research? Changing NIH Policies May Impact You

Similar documents
New NIH Clinical Trial Requirements for Grants & Contracts 2017/2018

Major Changes to NIH & AHRQ Submissions with Human Subjects

OSRA Updates. RAPID September 11 th 2017

NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information

Office Of Clinical Trials. Christine Nelson, RN, BSN, MBA, CCRC

Trends in Oversight of Human Research Protections?

POLICY AND PROCEDURE MANUAL

Clinical Research at MSU

ClinicalTrials.gov Registration Guide

COVER PAGE. Title: Regulatory Implications of Data-mining Author: Renee Harrell Word Count: 2387 COVER PAGE

TOPICS TOPICS. Navigating NIH 2016 Policy Changes for Grant Applications and Availability of Proposal Resources

WCG ACADEMY COURSE OVERVIEW

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network

ICH GCP E6(R2): Changes? Yes Challenges? Not as Difficult as You May Fear Lorrie D. Divers, President QRCP Solutions, Inc.

Applicability of US Regulations to Canadian Research

RECRUITING OF AND ADVERTISING FOR SUBJECTS

Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

Regulatory and Ethical Issues in Repository Research

2018 Common Rule Implementation Checklist

Investigator Manual. Human Subjects Protection Program

Protection of Research Participants: The IRB Process and the Winds of Change

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

April 13, Background

Advancing the Use of Central IRBs for Multicenter Clinical Trials

Rules of Human Experimentation

1 The Clinical Research Coordinator (CRC)... 1

Investigator Manual HRP-103

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Topics. Safety First Initiative. Drug Safety Communications DRUG SAFETY INITIATIVES AT THE FOOD AND DRUG ADMINISTRATION

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management

IND IND ACKNOWLEDGEMENT

Acting Deputy Commissioner for Operations, U.S. Food and Drug Administration

IRB-GCP and Timelines. Andrew Majewski, MSc. 1 st DOLF Meeting Washington University School of Medicine St Louis, Missouri-USA October th, 2010

GCP Refresher and GCP/GCDMP Trends. in the CTN. Denise King, MS, RD, CCRA & Lauren Yesko, BS. Presented by:

SWABIK Software Tools for the Exchange of Image Storage Media in Clinical Research (SWABIK)

Stanford University IRB Guidance On Data and Tissue Repositories

Technical Guidance on Clinical Evaluation of Medical Devices

External IRB Review What Does it Mean for Your Institution

CALL FOR COMBINED HEAT AND POWER (CHP) PROJECTS. Program Guide

Quality Assurance in Clinical Trials

Human Research Protection Program Guidance for Human Research Determination

Compliance Department RESEARCH COMPLIANCE MEMORANDUM

What is an IRB (Institutional Review Board)?

REGULATORY REQUIREMENTS FOR CLINICAL TRIAL APPROVAL MEDICAL DEVICES DR D DIALE MRS P NKAMBULE. 02 December 2015

Agenda: Opportunities in Developing Orphan Drug Products. Mukesh Kumar, PhD, RAC

Research Shared Services:

Introduction to Clinical Research

Forest Stewardship Council. Due Diligence Evaluation for the Association with FSC FSC-PRO V2-0 EN

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form

Institutional Review Board Compliance Elizabeth City State University

Technical Guidance on Clinical Evaluation of Medical Devices 1

Role of the IRB in Human Subjects Research

Job description and person specification

The Yale Open Data Access (YODA) Project: Lessons Learned in Data Sharing

Clinical Trial Transparency UK perspective

Joint statement on public disclosure of results from clinical trials

Conflict of Interest Policy

Supervisor/Manager Presentation. You and The PSD. Position Source Document

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

WRITING A SUCCESSFUL MSCA INDIVIDUAL FELLOWSHIP APPLICATION:! EVALUATOR S TIPS FOR PROPOSAL DRAFTING! AGORA GAMMA

SPARK Recruitment Process Document

Related Donor Informed Consent to Participate in Research

Summary of MRC Unit and Institute Quinquennial Reviews

Ethical Principles in Clinical Research

UVA Biorepository & Tissue Research Facility (BTRF) Coded-Specimens Guidance

Good Clinical Practice (GCP) & Clinical Trial Registries

Human Subjects Protection: Training for Research Teams

Certificate of Recognition (COR ) COR Program Guidelines. Infrastructure Health & Safety Association (IHSA) 05/17 1

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY

INTRODUCTION OF NEW EMPLOYMENT APPLICATION SYSTEM

PARTNERS HUMAN RESEARCH COMMITTEE. Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review

Data & Materials Sharing Agreement. Collaboration for AIDS Vaccine Discovery. Clinical Trials Data Sharing Addendum & Related Information

University of Virginia Cancer Center

Writing a Privacy Policy 101

MSA 690 Internship Handbook

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

Objectives. The Regulatory Binder = Investigator Site File= Trial Center File 8/16/2010. Essential Documents: Maintaining the Site's Regulatory Binder

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK

SOURCE SELECTION PLAN. {Insert if Phase I or Phase II} {Insert Project Name} {Insert Project Acronym} SOLICITATION XXXXXX-xx-R-xxxx

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

Patient Handbook on Stem Cell Therapies

Standard Operating Procedures Guidelines for Good Clinical Practice

Appendix G. Process For Protection of Proposal Information For 2016 Request For Proposals For Long-Term Renewable Generation Resources

Procedures for the Implementation of the ICIC Policy. Individual Conflict of Interest and Commitment Policy ROCHESTER INSTITUTE OF TECHNOLOGY

FRAMEWORK FOR POLICY DEVELOPMENT

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

BOARD OF DIRECTORS RYDER SYSTEM, INC. CORPORATE GOVERNANCE GUIDELINES

CTSI NIH KL2 SCHOLAR MULTIDISCIPLINARY PROGRAM APPLICATION INSTRUCTIONS

Expanded Access and the Individual Patient IND

Ethical Oversight of Human Subject Research. Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program

Professor Mervyn King Chairman International Integrated Reporting Council Submitted via

CDM DEFEND. Continuous Diagnostics and Mitigation (CDM) Dynamic and Evolving Federal Enterprise Network Defense (DEFEND) Industry Day May 15, 2017

The European Charter for Researchers and The Code of Conduct for the Recruitment of Researchers (C&C)

PROCEDURE CITY OF GRANDE PRAIRIE PURPOSE SCOPE PROHIBITIONS:

Information Security Education and Awareness Training

Responsible Property Investing Annual Report

Transcription:

Doing Human Subjects Research? Changing NIH Policies May Impact You

Reforms & Initiatives To enhance the stewardship of research involving human subjects, NIH is implementing the following: All Research Involving Human Participants New forms to collect human subjects information Use of a single Institutional Review Board (IRB) for multi-site studies Certificates of confidentiality for all research that uses identifiable, sensitive information Research that Meets the NIH Definition of a Clinical Trial Training in Good Clinical Practice (GCP) Clinical trial-specific Funding Opportunity Announcements (FOAs) New review criteria Expanded registration and results reporting in ClinicalTrials.gov

NIH Initiatives to Enhance Clinical Trial Stewardship Good Clinical Practice Single IRB Registration & Reporting Clinical Trial Review Criteria Clinical Trial FOAs New Application Forms Enhancing Clinical Trial Stewardship at NIH Accountability Transparency Efficiency Dissemination Learn more at https://grants.nih.gov/policy/clinical-trials.htm

NIH Might Consider Your Human Subjects Research to be a Clinical Trial Does your study Involve one or more human subjects? Prospectively assign human subject(s) to intervention(s)? Evaluate the effect of intervention(s) on the human subject(s)? Have a health-related biomedical or behavioral outcome? If yes to ALL of these questions, your study is considered a clinical trial Unsure how to answer the questions? We have a tool that can help! https://grants.nih.gov/ct-decision/

Identifying Whether NIH Considers Your Study to be a Clinical Trial is Crucial It impacts whether you need to: Respond to a clinical trial-specific FOA Address additional review criteria specific for clinical trials Register and report your clinical trial in ClinicalTrials.gov

Identifying the Right Funding Opportunity Announcement (FOA) is Key Due Dates on or after January 25, 2018 All clinical trial applications MUST be submitted to an FOA that allows clinical trials How to determine if an FOA accepts clinical trials? 1. Refer to Section II. Award Information 2. Indicated in FOA title (new FOAs only) Tip: Check your FOA at least 30 days before the due date for any updates

Good Clinical Practice (GCP) Training Who: What: Why: How: When: All NIH-funded investigators involved in the conduct, oversight or management of clinical trials Investigators are expected to receive Good Clinical Practice training To assure the safety, integrity, and quality of clinical trials Through a class or course, academic training program, or certification from a recognized clinical research professional organization Effective January 2017. Training should be refreshed every 3 years See https://grants.nih.gov/policy/clinical-trials/good-clinical-training.htm

Clinical Trial Specific Review Criteria FOAs will include additional criteria: Scored Review Criteria Significance Investigator Innovation Approach Environment Read the FOA carefully and be sure your application addresses the review criteria appropriately Additional Review Criteria Study Timeline & Milestones

New Application Packages (FORMS-E) Due Dates on or after January 25, 2018 FORMS-E Application Packages is REQUIRED (including new Human Subjects and Clinical Trials form) PHS Human Subjects and Clinical Trials Information Form Consolidates information from multiple forms Incorporates structured data fields Collects information at the study-level Be sure you are using the correct application forms for your due date. FORMS-E will be available October 2017. See https://grants.nih.gov/policy/clinical-trials/new-human-subject-clinical-trial-info-form.htm

Changes to the Appendix Policy Due Dates on or after January 25, 2018 Since the new Human Subjects and Clinical Trials Information form collects key elements from the protocol, the optional protocol submission will be removed from the Appendix Policy. Parent FOAs Will NEVER allow inclusion of the protocol in the application If the protocol is included, the application will be sent back IC issued FOAs Protocols and other materials allowed only when specified as required in the FOA See NIH Guide Notice: https://grants.nih.gov/grants/guide/notice-files/not-od-17-098.html

Registering & Reporting NIH-funded Clinical Trials in ClinicalTrials.gov Who: What: Why: When: All clinical trial applications requesting support for a trial that will be initiated on/after January 18, 2017 Register and report the results of trials in ClinicalTrials.gov Increase the availability of information about clinical trials and their results to the public in a timely manner Effective for applications due on/after January 18, 2017 See https://grants.nih.gov/policy/clinical-trials/reporting/steps.htm

Single Institutional Review Board (sirb) Policy for Multi-site Research Domestic multi-site non-exempt human subjects research studies will require a single IRB of record Key Dates Grants: Applications due on or after January 25, 2018 Contracts: Solicitations published starting January 25, 2018 Exceptions sirb not applicable for Career Development (K), Research Training (T), or Fellowship (F) See https://grants.nih.gov/policy/clinical-trials/single-irb-policy-multi-site-research.htm

Updated Certificates of Confidentiality (CoC) Policy Effective October 1, 2017 - CoCs will be issued automatically for any NIH-funded project using identifiable, sensitive information that was on-going on/after December 13, 2016 Eliminates the need for NIH funded investigators to apply for a CoC Enhances the privacy protections of individuals participating in NIH-funded research Requires investigators to only disclose information under specific circumstances Applies to NIH awards funded wholly, or in part, by NIH Disclosure restrictions also apply to anyone who receives a copy of identifiable sensitive information protected by the policy, even if they are not funded by NIH CoC is issued as a term and condition of award (no physical certificate) Learn more at https://humansubjects.nih.gov/coc/index